Quest Diagnostics Incorporated (DGX) — Analyst outlook / Analyst consensus target is. Based on 34 analyst ratings, the consensus is bullish — 13 Buy, 18 Hold, 3 Sell.
The consensus price target is $215.10 (low: $200.00, high: $235.00), representing an upside of 10.8% from the current price $194.16.
Analysts estimate Earnings Per Share (EPS) of $8.90 and revenue of $9.83B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $7.80 vs est $8.90 (missed -12.4%). 2025: actual $8.87 vs est $9.81 (missed -9.6%). Analyst accuracy: 88%.
DGX Stock — 12-Month Price Forecast
$215.10
▲ +10.78% Upside
Average Price Target
Based on 34 Wall Street analysts offering 12-month price targets for Quest Diagnostics Incorporated, the average price target is $215.10, with a high forecast of $235.00, and a low forecast of $200.00.
The average price target represents a +10.78% change from the last price of $194.16.
Highest Price Target
$235.00
Average Price Target
$215.10
Lowest Price Target
$200.00
DGX Analyst Ratings
Hold
Based on 34 analysts giving stock ratings to Quest Diagnostics Incorporated in the past 3 months
EPS Estimates — DGX
88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $7.80
vs Est $8.90
▼ 14.1% off
2025
Actual $8.87
vs Est $9.81
▼ 10.6% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — DGX
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $9.872B
vs Est $9.830B
▲ 0.4% off
2025
Actual $11.035B
vs Est $10.984B
▲ 0.5% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
